Bristol-Myers Squibb's lucrative Opdivo fails lung cancer trail
… cancers - had failed in a lungcancer trial.
Its stock fell 16 … slowing the progression of advanced lungcancer.
Cancer is second only to … Centers for Disease Control. And lungcancer ranks as the leading cause …
No comments:
Post a Comment